Intravascular contrast agents suitable for magnetic resonance imaging.
- 1 October 1984
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 153 (1) , 171-176
- https://doi.org/10.1148/radiology.153.1.6433402
Abstract
Two paramagnetic chelates, Cr EDTA and gadolinium DTPA [diethylenetriaminepentaacetic acid), were evaluated as potential i.v. contrast agents for magnetic resonance imaging (MR) using a 0.5-T superconducting scanner. After evaluating both agents in vitro, in vivo studies were conducted in dogs to document changes in renal appearance produced by contrast injection. Acute splenic and renal infarction were diagnosed with contrast-enhanced MR, and confirmed by gamma camera imaging following administration of 99mTc-labeled DMSA and sulfur colloid. I.v. paramagnetic contrast agents presently offer the best mechanism for assessment of tissue function and changes in perfusion with MR.This publication has 4 references indexed in Scilit:
- Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complexAmerican Journal of Roentgenology, 1984
- Characteristics of gadolinium-DTPA complex: a potential NMR contrast agentAmerican Journal of Roentgenology, 1984
- Clinical NMR imaging of the brain: 140 casesAmerican Journal of Roentgenology, 1982
- Preliminary experimental results in humans and animals with a superconducting, whole-body, nuclear magnetic resonance scanner.Radiology, 1982